Approach to radiation therapy in the Jehovah's Witness patient: An overview

被引：0

作者：

Jurica, James M. ^{[1
,2
]}

Messer, Jay A. ^{[2
,3
]}

Teh, Bin S. ^{[1
]}

Butler, Brian E. ^{[1
]}

Farach, Andrew M. ^{[1
]}

机构：

[1] Baylor Coll Med, Houston, TX 77030 USA

[2] Houston Methodist Hosp, Dept Radiat Oncol, 6565 Fannin St,Ste DB1-077, Houston, TX 77030 USA

[3] Univ Texas Med Branch, Dept Radiat Oncol, Galveston, TX 77555 USA

来源：

REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY | 2020年 / 25卷 / 06期

关键词：

Jehovah witness; Radiation oncology; Anemia; Hematologic toxicity; Bone marrow sparing; BMS-IMRT; DOSIMETRIC ANALYSIS; CANCER; ANEMIA; ASSOCIATION; PREVALENCE;

D O I：

10.1016/j.rpor.2020.08.014

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Jehovah's Witnesses are well-known in the medical community for their inability to accept blood products. Novel methods of treatment are often needed to avoid anemia and hematologic toxicity as inability to receive blood products may increase the risk of treatment related complications. We provide an overview of radiation treatment for Jehovah's Witness patients with an emphasis on bone marrow sparing strategies with intensity modulated radiation therapy (IMRT) to minimize hematologic toxicity. (C) 2020 Greater Poland Cancer Centre. Published by Elsevier B.V. All rights reserved.

引用

页码：856 / 859

页数：4

共 50 条

[1] Poll - Jehovah's Witness Patient
Grinberg, Max
Chehaibar, Graziela Zlotnik
ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2010, 95 (06) : 765 - 766
[2] Approach to Polytrauma in a Jehovah's Witness
Tallowin, S.
Beaven, A.
BRITISH JOURNAL OF SURGERY, 2015, 102 : 130 - 130
[3] A suggested approach to epidural blood patch in a Jehovah's Witness patient
Napoleon, J. L.
May, K. A.
Craven, J. M.
INTERNATIONAL JOURNAL OF OBSTETRIC ANESTHESIA, 2023, 55
[4] Cell salvage in the Jehovah's Witness patient
Waters, JH
Potter, PS
ANESTHESIA AND ANALGESIA, 2000, 90 (01): : 229 - 230
[5] Lung transplant in Jehovah's Witness patient
Cerezo Madueno, Francisco
Arango Tomas, Elisabet
Salvatierra Velazquez, Angel
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2013, 145 (06): : E65 - E67
[6] Erythropoietin use in a Jehovah's Witness patient
Walton, T
Macon, EJ
ANNALS OF PHARMACOTHERAPY, 2002, 36 (04) : 729 - 730
[7] Peripartum Care of the Jehovah's Witness Patient
Riveros-Perez, Efrain
Kacmar, Rachel
CLINICAL OBSTETRICS AND GYNECOLOGY, 2017, 60 (02): : 394 - 404
[8] Haematological care of the Jehovah's witness patient
Marsh, JCW
Bevan, DH
BRITISH JOURNAL OF HAEMATOLOGY, 2002, 119 (01) : 25 - 37
[9] Preanesthetic Assessment of the Jehovah's Witness Patient
Lin, Eric S.
Kaye, Alan D.
Baluch, Amir R.
OCHSNER JOURNAL, 2012, 12 (01): : 61 - 69
[10] Vemurafenib as bridging therapy of hairy cell leukemia in a Jehovah’s Witness patient
Sebastian Schlaweck
Peter Brossart
Annkristin Heine
Annals of Hematology, 2022, 101 : 217 - 218

← 1 2 3 4 5 →